Veracyte Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Veracyte (VCYT)
Veracyte Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Veracyte (VCYT) |
| [05-November-2026] |
Veracyte stock fell more than 50% after the Company reported on November 4, 2026 that Decipher Prostate volume fell short of its expectations. Levi and Korsinsky investigates into potential securities law violations. NEW YORK, Nov. 5, 2026 /PRNewswire/ -- Veracyte (NASDAQ: VCYT) shareholders are taking losses after the Company's November 4, 2026 third-quarter report showed Decipher Prostate test volume short of management's own expectations. If you held VCYT through the decline, you may have legal rights. Investors who lost money are encouraged to report their VCYT losses here . You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.
Veracyte's previously projected additional testing volume for Decipher fell sharply alongside the third-quarter results. Last quarter, on July 30, 2026, the Company projected "around 20,000 tests a year, plus or minus 1,000 or so." Following third-quarter results, the Company now projects only 12,000 to 15,000. Discrete financial guidance was reduced as well. Veracyte now projects total 2026 revenue guidance of $590 million to $593 million, a 3 million reduction from the top line of the range from the previous guidance. Particularly, testing guidance was reduced from a previous guidance of $576 million to $582 million, the company now expects roughly just $572 million. VCYT shareholders with losses can start a free confidential loss review or call (212) 363-7500. WHY LEVI & KORSINSKY -- Ranked in ISS Securities Class Action Services' Top 50 Report for seven consecutive years, Levi & Korsinsky, LLP is a nationally recognized leader in shareholder rights litigation. With a team of over 70 professionals, the firm has recovered billions of dollars for investors. Frequently Asked Questions About the VCYT Investigation Q: Who is eligible to participate in the VCYT investigation? A: Investors who purchased VCYT stock or securities and suffered financial losses may be eligible. Eligibility is based on purchase date and documented losses -- not on whether you still hold the shares. Q: Which statements are being investigated as potentially misleading? A: The investigation concerns whether Veracyte's statements about the growth outlook for its Decipher Prostate test were accurate and complete. The stock price declined after the Company disclosed on November 4, 2026 that Decipher Prostate volume was below its expectations. Q: When did Veracyte allegedly mislead investors? A: The investigation concerns statements made before the November 4, 2026 disclosure that allegedly caused investors to purchase securities at inflated prices. Q: What do VCYT investors need to do right now? A: Investors may gather brokerage records showing purchase dates, share quantities, and prices paid. Submit your information for a no-cost, no-obligation evaluation of your potential recovery . No immediate action is required to remain eligible to participate in the investigation. Q: What documents do I need to participate? A: Brokerage statements or trade confirmations showing purchase dates, share quantities, prices paid, and any subsequent sale dates and prices. Q: What if I already sold my VCYT shares -- can I still recover losses? A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought VCYT and sold at a loss may still participate in the investigation. Q: What does it cost me to participate? A: There is no upfront cost to submit your information and review whether you may be eligible to recover. Should you choose to participate in any resulting action, these matters are generally handled on a contingency basis, with any attorneys' fees and expenses subject to court approval. Q: Do I need to go to court or give testimony? A: No. Participating in the investigation does not require court appearances or depositions. If legal action is later pursued, the overwhelming majority of affected investors never appear in court either. CONTACT: Attorney Advertising. Prior results do not guarantee similar outcomes.
SOURCE Levi & Korsinsky, LLP | ||
Company Codes: NASDAQ:VCYT |
View original content to download multimedia:
